Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
Ethris Presents Positive Topline Phase 1 Data with mRNA Lead Candidate ETH47 for Uncontrolled Asthma
05:00am, Thursday, 30'th Jan 2025
MUNICH, Germany--(BUSINESS WIRE)--Ethris GmbH, a leading biotechnology company pioneering next-generation RNA therapeutics and vaccines, today announced promising topline data from the completed Phase
Moderna Stock Falls After Goldman Downgrade. Vaccine Sales Are a Worry.
09:51am, Wednesday, 29'th Jan 2025
Goldman Sachs downgraded the vaccine maker to Neutral from Buy and slashed its stock-price target to $51 from $99 Wednesday.
Moderna Stock Falls on Vaccine Revenue Concerns
09:00am, Wednesday, 29'th Jan 2025
Shares of Moderna Inc. (NASDAQ: MRNA) are down 3.2% in premarket trading after a bear note from Goldman Sachs.
Moderna's stock is falling. Goldman Sachs says it's no longer a buy.
08:50am, Wednesday, 29'th Jan 2025
Shares of vaccine maker Moderna fell Wednesday as Goldman Sachs lowered its rating after the biotech's second cut to product revenue guidance in six months.
The RFK Jr. Effect: Biotech Stocks Brace For 'Games' In Senate Hearings
08:00am, Wednesday, 29'th Jan 2025
Biotech stocks will need to brace for political "games" Wednesday as the Senate meets to potentially confirm RFK Jr. to lead HHS. The post The RFK Jr. Effect: Biotech Stocks Brace For 'Games' In Senat
Moderna to Report Fourth Quarter and Full Year 2024 Financial Results on Friday, February 14, 2025
07:00am, Wednesday, 29'th Jan 2025
CAMBRIDGE, MA / ACCESS Newswire / January 29, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, February 14, 2025 to re
Moderna (MRNA) Increases Despite Market Slip: Here's What You Need to Know
06:56pm, Monday, 27'th Jan 2025
In the latest trading session, Moderna (MRNA) closed at $41.66, marking a +0.6% move from the previous day.
5 Stocks That Powered S&P 500 ETF in Trump's First Week
12:31pm, Monday, 27'th Jan 2025
The S&P 500 logs the best first week of a presidential term in four decades. Here are five stocks in the ETF that led the gains.
Why Moderna Stock Jumped Over 20% This Week
03:11pm, Saturday, 25'th Jan 2025
Shares of Moderna (MRNA -2.31%) zoomed as much as 33.3% higher this week, according to data from S&P Global Market Intelligence.
3 Things You Need to Know if You Buy Moderna Today
10:30am, Saturday, 25'th Jan 2025
Based on its share price, down 75% in the last three years, it's easy to write off Moderna (MRNA -2.31%) as a biotech that'll never recover its former glory -- which it built on the success of its cor
3 Beaten-Down Stocks That Haven't Been This Cheap in More Than 3 Years: Are They Bargain Buys?
04:23am, Saturday, 25'th Jan 2025
If a stock is near its 52-week low, it may be a great time to buy it on the dip, particularly if you're bullish on its long-term prospects. But what about when it's trading at more of a discount, and
Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union
06:30am, Friday, 24'th Jan 2025
The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats CAMBRIDGE, MA / ACCESS Newswir
A norovirus vaccine could be on the horizon as cases rise
01:58pm, Thursday, 23'rd Jan 2025
Moderna is testing a norovirus vaccine in a phase three trial, with results available as soon as this year. Norovirus cases are on the rise this winter, with outbreaks already up more than 30% by Dece
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:50am, Thursday, 23'rd Jan 2025
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Moderna Surges After Larry Ellison Calls Out The Potential Of AI In Cancer Vaccines
12:53pm, Wednesday, 22'nd Jan 2025
Moderna stock surged Wednesday after Oracle Chairman Larry Ellison praised the potential of AI in developing medicines. The post Moderna Surges After Larry Ellison Calls Out The Potential Of AI In Can
